1.92
전일 마감가:
$1.98
열려 있는:
$1.98
하루 거래량:
423.37K
Relative Volume:
0.91
시가총액:
$187.16M
수익:
$32.38M
순이익/손실:
$-21.64M
주가수익비율:
-7.6281
EPS:
-0.2517
순현금흐름:
$-13.78M
1주 성능:
-5.42%
1개월 성능:
+7.26%
6개월 성능:
-37.05%
1년 성능:
+5.49%
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STXS
Stereotaxis Inc
|
1.92 | 193.01M | 32.38M | -21.64M | -13.78M | -0.2517 |
|
ISRG
Intuitive Surgical Inc
|
451.29 | 165.37B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.69 | 45.13B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
47.51 | 39.17B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
77.82 | 39.14B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
221.22 | 32.94B | 5.40B | 1.49B | 1.78B | 10.12 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
After the close, Stereotaxis will break down Q1 results on May 12 - Stock Titan
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 - Yahoo! Finance Canada
Net current asset value per share of Stereotaxis, Inc. – LSX:A1J09L - TradingView
Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - MSN
Stereotaxis to Acquire Robocath in Strategic 45 Million Dollar Deal - HarianBasis.co
Stereotaxis, Inc. sets sights on HRS2026 with live robotics demonstration - Traders Union
STXS to Acquire Robocath to Lead in Endovascular Robotics Market - Yahoo Finance
Stereotaxis to acquire Robocath for up to $45m - Yahoo Finance
Stereotaxis (STXS) to Acquire Robocath in Multi-Million Dollar D - GuruFocus
Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover - Benzinga
Stereotaxis to buy Robocath for up to $45M - MedTech Dive
Stereotaxis to Buy Robocath for up to $45M - Medical Product Outsourcing
St. Louis robotic surgery firm acquires French competitor - The Business Journals
Stereotaxis to Acquire Robocath in Strategic Robotics Deal - TipRanks
Stereotaxis to Acquire Robocath in Deal Worth Up to $45 Million - marketscreener.com
Stereotaxis to Acquire Robocath With $20M Upfront, Up to $25M Earnouts; Provides Interim Financing - TradingView
Stereotaxis to acquire Robocath for up to $45 million By Investing.com - Investing.com Canada
Stereotaxis (STXS) plans Robocath acquisition with $20M upfront and $25M earnout - Stock Titan
Stereotaxis Announces Definitive Agreement to Acquire Robocath - ChartMill
Stereotaxis, Inc. agreed to acquire an unknown majority stake in Robocath SAS for $45 million. - marketscreener.com
Stereotaxis, Inc. urges final day visits at EHRA2026 for hands on robotic EP demonstrations - Traders Union
Stereotaxis (STXS) CFO awarded 40,000 options at $1.87 strike price - Stock Titan
Aug Drivers: Is Stereotaxis Inc being accumulated by smart money2026 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Inflation Data: Can Stereotaxis Inc keep up with sector leaders2026 Trading Volume Trends & Community Driven Trade Alerts - baoquankhu1.vn
Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN
Stereotaxis, Inc. promotes GenesisX at EHRA2026 kickoff in Paris - Traders Union
Bank Watch: Does Stereotaxis Inc align with a passive investing strategy2026 Year in Review & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Stereotaxis bags FDA clearance for next-gen cath lab tech - Indian Pharma Post
St. Louis-based Stereotaxis gets FDA clearance for new cath lab software platform - The Business Journals
Stereotaxis wins FDA clearance for Synchrony system, launches platform - MSN
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance Australia
STXS Rises After FDA Approval for Synchrony System, Broadens Digital Surgery Portfolio - Bitget
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery - TradingView
Stereotaxis (STXS) Gains FDA Clearance for Synchrony System - GuruFocus
New Highs: Does Stereotaxis Inc have consistent dividend growth2026 EndofYear Setup & Daily Profit Focused Screening - baoquankhu1.vn
Stereotaxis, Inc. gains FDA clearance for Synchrony robotics system - Traders Union
Stereotaxis Shares Rise on FDA Clearance for Synchrony - marketscreener.com
Stereotaxis’ Synchrony System Gets FDA OK & Launches - Medical Product Outsourcing
Stereotaxis Announces FDA Clearance and Launch of Synchrony System - GlobeNewswire
S P Trends: Should I buy Stereotaxis Inc stock now2026 PreEarnings & Technical Entry and Exit Tips - baoquankhu1.vn
Stereotaxis, Inc. 2025 Amended Annual Report (10-K/A): Key Financials, Certifications, and XBRL Filings - Minichart
STXS Technical Analysis & Stock Price Forecast - Intellectia AI
Stereotaxis, Inc. (STXS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Stereotaxis (NYSE: STXS) files 10-K amendment adding EY consent - Stock Titan
Stereotaxis (NYSE: STXS) details 2026 meeting, director elections and say-on-pay - Stock Titan
Live-in-the-Box robotic session to feature Sabine Ernst at EHRA2026, Stereotaxis, Inc. unveils - Traders Union
Citizens upgrades Stereotaxis stock outlook on catheter ramp By Investing.com - Investing.com Canada
STXS PE Ratio & Valuation, Is STXS Overvalued - Intellectia AI
Stereotaxis, Inc. expands remote robotic testing with TeleRobotic Test Drive launch - Traders Union
Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - msn.com
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):